CONTENTSIN MY OPINIONLAST WORD3008Dr. Linda Randall, AVP, Biologics Development, Manufacturing & Control, PharmaronJesper Lekdorf, MD, Sr. Medical Director, Head of Medical Affairs, Novo NordiskThe Tipping Point for Scalable Manufacturing Processes to Pivot Gene TherapiesImprovements in insulin delivery over time and expectations for the future12 COVER STORYALIGNING EVIDENCE AND PRICING TO SUPPORT INNOVATION AS THE BELT TIGHTENSSusanne Michel, Head of HTA EvidenceMichael J. Epstein, Head of Commercial Strategy
< Page 3 | Page 5 >